Uscom (ASX:UCM) - Executive Chairman, Rob Phillips
Executive Chairman, Rob Phillips
Source: Uscom
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Uscom (UCM) has announced its subsidiary, Uscom China, was listed second as a National High Technology Enterprise by China
  • Receiving this listing is a recognition of Uscom’s achievements in research and development, innovation, and significant findings in high-tech fields
  • Once they’re listed, they’re encouraged to keep up the momentum and are given additional support by state departments, including the Ministry of Science and Technology of China
  • Uscom China manufactures and sells different ultrasonic technologies which optimise respiratory devices
  • Over the next 12 months, five new products are expected to receive Chinese regulatory approval and enter the market, with another two in the pipeline
  • Company shares are up 12.5 per cent and are trading at 18 cents

Uscom (UCM) has announced its subsidiary, Uscom China, was listed second as a National High Technology Enterprise by China.

Specifically, the Chinese Office of the Leading Group of National High Technology Enterprise Identification and Management listed the Chinese subsidiary.

This list was released by the Torch High Technology Industry Development Centre which is a department of the Ministry of Science and Technology (MOST) of China.

High Technology Enterprises are recognised for their achievements in research and development, innovation, generating intellectual property and significant findings in high-tech fields. Once they’re listed, they’re encouraged to keep up the momentum and are given additional support by state departments, including MOST.

Listed companies receive benefits such as a tax exemption, grants from 50,000 to over one million RMB, priority for government tenders, accelerated depreciation of fixed assets snd facilitation of future fundraising and bank loans.

Uscom has operated in China for more than 15 years and, in 2018, it opened its wholly-owned Chinese subsidiary in Beijing.

This year, Uscom China has registered 12 software copyrights, 13 trademarks and four trademark copyrights with the National Copyright Administration of China. This protects the company’s core technologies and algorithms in the Chinese market.

Uscom manufactures and sells the USCOM 1A, the Uscom BP+, and the Uscom SpiroSonic digital ultrasonic spirometry technologies. It also develops the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimising the performance of respiratory devices.

This year, COVID-19 has led to the medical equipment sector being flooded with maturing respiratory devices. However, Uscom’s devices — in particular, the SpiroSonic Ventitest device — has been in the making for 15 years, undergoing extensive production and testing.

“This state recognition opens many doors for us and underwrites our future in China, and we look forward to continuing our record growth with the Chinese economy as it leads the world in recovery and expansion,” Executive Chairman Professor Rob Phillips said.

Over the next 12 months, five new products are expected to receive Chinese regulatory approval and enter the market. Following this, two more products are in the pipeline for entry within the next 24 months.

Company shares are up 12.5 per cent and are trading at 18 cents at 12:28 pm AEDT.

UCM by the numbers
More From The Market Online
medical patient

Drove autonomous wheelchair gets TGA approval

Control Bionics (ASX: CBL) has announced that its autonomous wheelchair module, DROVE, has been officially included as a Class 1 Medical Device

Biotron jumps over 14% on latest HIV Phase 2 results; liquidity notably boosted

Shares in otherwise thinly traded healthcare microcap Biotron Limited (ASX:BIT) jumped 14.6% on Wednesday following trial…

Recce breathes better on positive lung infection drug pilot test results

Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327,…

Proteomics appoints Growth Medics to drive European sales

Proteomics International Laboratories has engaged Growth Medics B.V., to assist with the selection of EU alliance…